latam

Regístrate
Invertir conlleva riesgos y puede no ser adecuado para todos los inversores.

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

LLY

916.07

-0.02%↓

UNH

566.13

-0.87%↓

NVO

118.17

+0.23%↑

JNJ

164.55

+0.16%↑

ABBV

188.57

-1%↓

Inicio・Lista de Acciones・Catalent Inc
Search

Catalent Inc

Cerrado

Sector Salud

60.26 -0.56

Neutral

Precios actualizados 16 oct 2024, 19:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

60.12

Máximo

60.6

Métricas clave

By Trading Economics

Ingresos

124M

23M

Ventas

180M

1.3B

P/B

Media del Sector

28.82

112.16

BPA

0.65

Margen de beneficio

1.769

EBITDA

83M

105M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+5.34 upside

Dividendos

By Dow Jones

Próximas Ganancias

13 nov 2024

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

3.6M

11B

Apertura anterior

60.82

Cierre anterior

60.26

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

172 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

60.09 / 60.6099 Soporte y Resistencia

Catalent Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 may 2024, 13:51 UTC

Adquisiciones, fusiones, absorciones

FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal

DJ

Leer

5 feb 2024, 14:50 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 4th Update

DJ

Leer

5 feb 2024, 13:11 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 3rd Update

DJ

Leer

5 feb 2024, 12:09 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings to Buy Catalent in $16.5 Billion Deal -- 2nd Update

DJ

Leer

5 feb 2024, 11:38 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Buys Manufacturing Sites as Part of Novo Holdings' Acquisition of Catalent

DJ

Leer

5 feb 2024, 11:31 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings Buying Catalent in $16.5 Billion Deal -- Update

DJ

Leer

5 feb 2024, 11:23 UTC

Adquisiciones, fusiones, absorciones

Novo Holdings Buying Catalent in $16.5 Billion Deal

DJ

Leer

23 mar 2024, 13:00 UTC

Principales Noticias

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

DJ

Leer

5 feb 2024, 18:04 UTC

Adquisiciones, fusiones, absorciones

Wegovy Maker to Boost Production Capacity With Multibillion-Dollar Deal -- WSJ

DJ

Leer

5 feb 2024, 17:27 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Novo Nordisk Makes the Latest Big Pharma Deal. Why More Are Coming. -- Barrons.com

DJ

Leer

5 feb 2024, 15:36 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk To Up Production Capacity As Parent Buys Catalent -- IBD

DJ

Leer

5 feb 2024, 11:38 UTC

Adquisiciones, fusiones, absorciones

Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk -- Barrons.com

DJ

Leer

5 feb 2024, 11:15 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk's Controlling Shareholder To Buy Catalent For $16.5 Billion -- MarketWatch

DJ

Leer

5 feb 2024, 11:08 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk: Manufacturing Sites Are in Italy, Belgium and US

DJ

Leer

5 feb 2024, 11:08 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Buys Sites From Novo Holdings as Part of Novo Holdings' Deal to Buy Catalent

DJ

Leer

5 feb 2024, 11:06 UTC

Adquisiciones, fusiones, absorciones

Novo Nordisk Agrees to Buy Three Manufacturing Sites For Upfront Payment of $11 Bln

DJ

Leer

5 feb 2024, 11:03 UTC

Adquisiciones, fusiones, absorciones

Catalent: Merger Is Expected to Close Towards the End of Calendar Yr 2024 >CTLT

DJ

Leer

5 feb 2024, 11:02 UTC

Adquisiciones, fusiones, absorciones

Catalent: Of Co's More Than 50 Global Sites, Novo Holdings Intends to Sell Three Catalent Fill-Finish Sites and Related Assets Acquired in Merger to Novo Nordisk >CTLT

DJ

Leer

Comparación entre iguales

Cambio de precio

Catalent Inc Esperado

Precio Objetivo

By TipRanks

5.34% repunte

Estimación a 12 meses

Media 63.5 USD  5.34%

Máximo 63.5 USD

Mínimo 63.5 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Catalent Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

1 ratings

0

Comprar

1

Mantener

0

Vender

De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para Catalent Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

60.09 / 60.6099Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Medio plazo

Bearish Evidence

Bearish events outweigh bullish events.

Largo Plazo

Weak Bearish Evidence

There is one bearish event.

Sentimiento

By Acuity

172 / 366 Clasificación en Salud

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Catalent Inc

Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.

Otras acciones del sector

LLY

Eli Lilly and Co.

916.07

↓-0.02%

UNH

UnitedHealth Group Inc

566.13

↓-0.87%

NVO

Novo Nordisk A-S

118.17

↑ +0.23%

JNJ

Johnson and Johnson

164.55

↑ +0.16%

ABBV

AbbVie Inc

188.57

↓-1%